BPC-157

BPC-157 is a stable gastric pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of approximately 1419.5 g/mol. Unlike many bioactive peptides, BPC-157 demonstrates notable stability in gastric juice and does not require carrier proteins for experimental activity in published preclinical models. This stability profile makes it a practical research compound for both in-vitro and ex-vivo experimental designs.

BPC-157 research centers on its proposed cytoprotective, angiogenic, and tissue-repair-associated properties observed in preclinical animal models. Published studies have examined its effects on tendon, ligament, muscle, and gastrointestinal tissue healing in rodent models. Researchers investigating growth factor modulation, nitric oxide system interactions, and wound healing biology use BPC-157 as a tool compound in controlled experimental systems.

Every batch of BPC-157 is synthesized using Solid-Phase Peptide Synthesis (SPPS) and purified via preparative HPLC to eliminate truncated sequences and synthesis byproducts. Final identity confirmation is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular weight. Each lot ships with a Certificate of Analysis documenting purity exceeding 99%, giving researchers traceable, batch-specific verification before use in any laboratory protocol.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.